Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retrace is a private healthtech company focused on oral healthcare payments, billing, and claims automation rather than therapeutic drug development. The company offers an AI-enabled platform that connects dental providers, payers, and patients to improve treatment validation, billing accuracy, and payment speed. Its products are positioned as a dental payment network and intelligent automation tools for office and claims workflows. Retrace appears to operate commercially in the U.S. dental market and has emphasized healthcare data security and clearinghouse-grade infrastructure. For a biotech analyst, this is best understood as a healthcare infrastructure and dental AI software company, not a traditional biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retrace.